Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Avai Bio Inc (AVAI)

Avai Bio Inc (AVAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield (Fwd) N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector N/A
  • INDUSTRY GROUPING N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.3500 unch
on 03/13/26
0.4758 -26.44%
on 02/17/26
-0.0818 (-18.94%)
since 02/13/26
3-Month
0.2600 +34.62%
on 12/31/25
0.8000 -56.25%
on 01/16/26
+0.0201 (+6.09%)
since 12/12/25
52-Week
0.2600 +34.62%
on 12/31/25
0.8277 -57.71%
on 06/06/25
-0.0119 (-3.29%)
since 03/13/25

Most Recent Stories

More News
Stocks in play: Avai Bio Inc

Announced--together with its joint venture partner and global biotechnology firm, Austrianova--the initiation ...

AVAI : 0.3742 (+3.23%)
Investors Eye Explosive Growth in Anti-Aging Therapies as Market Targets $420B Milestone

EQNX::TICKER_START (OTCQB:AVAI),(NASDAQ:GERN),(NASDAQ:NTLA),(NASDAQ:NAGE),(NASDAQ:OCGN) EQNX::TICKER_END

AVAI : 0.3742 (+3.23%)
NAGE : 4.88 (+1.24%)
GERN : 1.6050 (+0.31%)
NTLA : 13.06 (+1.63%)
OCGN : 2.65 (+13.25%)
Stocks in play: Avant Technologies Inc

Announced the completion of its corporate name change to Avaí Bio, Inc. The rebranding, effective today, ...

AVAI : 0.3742 (+3.23%)
Stocks in play: Avant Technologies Inc

Announced its participation in the 15th European Pancreas and Islet Transplantation Association (EPITA) ...

AVAI : 0.3742 (+3.23%)
Stocks in play: Avant Technologies Inc

Highlights the essential importance of cell encapsulation technology in enabling effective, long-term ...

AVAI : 0.3742 (+3.23%)
Beyond Weight Loss: The "Cellular Reset" That Could Create the Next Biotech Supercycle

Issued on behalf of Avant Technologies Inc. VANCOUVER – Baystreet.ca News Commentary – The longevity economy is entering a massive repricing event as researchers confirm that metabolic dysfunction...

LGVN : 0.9721 (+20.16%)
AVAI : 0.3742 (+3.23%)
BIOA : 19.70 (-0.96%)
GAA : 33.94 (+0.35%)
DNLI : 20.64 (-0.29%)
MAPT : 0.0002 (+100.00%)
KLTO : 0.5242 (+0.81%)
Stocks in play: Avant Technologies Inc

Announced a newly published study from the Mayo Clinic reinforces the critical role of the “longevity ...

AVAI : 0.3742 (+3.23%)
Avant Technologies and Austrianova Advancing α-Klotho Cell Therapy as Mayo Clinic Study Links Low α-Klotho Levels to Poor Cardiovascular Survival

Avant Technologies Inc. (OTCQB: AVAI) (“Avant” or the “Company”), an emerging biotechnology company focused on developing cellbased therapies for diabetes and age-related disorders, today announced...

AVAI : 0.3742 (+3.23%)
Stocks in play: Avant Technologies Inc

Announced that its 50/50 joint venture with Austrianova has entered into an exclusive, worldwide License ...

AVAI : 0.3742 (+3.23%)
Metabolic Reset: Cell Therapies and Novel Drugs Reshape Chronic Disease Market

VANCOUVER – Baystreet.ca News Commentary – The metabolic disorder therapeutics market projects growth to $120.7 billion by 2030 as biotechnology firms pioneer organ-level treatments addressing diabetes,...

AVAI : 0.3742 (+3.23%)
TNDM : 21.83 (+4.55%)
CRNX : 36.58 (+0.19%)
MDGL : 439.66 (+0.21%)
ALT : 3.61 (+0.28%)

Key Turning Points

3rd Resistance Point 0.3950
2nd Resistance Point 0.3875
1st Resistance Point 0.3750
Last Price 0.3742
1st Support Level 0.3550
2nd Support Level 0.3475
3rd Support Level 0.3350

See More

52-Week High 0.8277
Fibonacci 61.8% 0.6108
Fibonacci 50% 0.5439
Fibonacci 38.2% 0.4769
Last Price 0.3742
52-Week Low 0.2600

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar